循证跨性别医疗的障碍:性别肯定子宫切除术与卵巢切除术的知识空白
本文为评论文章,回顾支持跨性别男性性别肯定子宫切除术与卵巢切除术安全性、可行性及手术途径的证据,并讨论顺性别女性卵巢切除术的风险外推及睾酮补充的影响。文章指出目前缺乏循证指南界定这些手术的最佳治疗,卵巢切除术是否同期进行存在数据空白,需未来研究明确最佳实践。
要点
- 证据支持跨性别男性性别肯定子宫切除术与卵巢切除术的安全性、可行性和医疗必要性。
- 顺性别女性卵巢切除术与心血管事件增加和全因死亡率升高相关,可能归因于雌激素水平降低。
- 跨性别男性卵巢切除术的结局数据不足,无法推断相同的潜在发病率和死亡率。
核心结论
- 目前没有循证指南界定跨性别男性性别肯定子宫切除术和卵巢切除术许多方面的最佳治疗。
- 跨性别男性卵巢切除术的结局数据不足,无法就潜在发病率和死亡率做出与顺性别女性相同的推断。
- 作者认为医生有责任为跨性别患者提供循证的妇科性别肯定治疗建议并避免潜在伤害。
研究设计与样本
- 本文为评论文章,回顾支持跨性别男性性别肯定子宫切除术与卵巢切除术安全性、可行性及手术途径的证据。
- 文章还回顾顺性别女性卵巢切除术的获益与风险及其向跨性别男性的外推,以及睾酮补充对跨性别男性的影响。
主要发现
- 过去20年美国性别肯定手术可及性大幅增加,与性别歧视性保险覆盖政策的逆转有关。
- 顺性别女性卵巢切除术与心血管事件增加和全因死亡率升高相关,最可能归因于雌激素水平降低。
- 跨性别男性卵巢切除术的结局数据不足,无法就潜在发病率和死亡率做出与顺性别女性相同的推断。
- 子宫切除术时是否应同时行卵巢切除术存在数据空白。
临床怎么用
- 作者认为医生有责任为跨性别患者提供循证的妇科性别肯定治疗建议并避免潜在伤害。
- 文章在性别肯定手术数量增加的背景下指出了未来研究以阐明最佳实践的领域。
局限性
- 目前没有循证指南界定跨性别男性性别肯定子宫切除术和卵巢切除术许多方面的最佳治疗。
- 跨性别男性卵巢切除术的结局数据不足,无法就潜在发病率和死亡率做出与顺性别女性相同的推断。
- 子宫切除术时是否应同时行卵巢切除术存在数据空白。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Reversal of gender-discriminatory insurance coverage policies has led to a substantial increase in access to gender-affirming surgical care in the United States over the past 20 years. Although the evidence supports the safety, feasibility, and medical necessity of gender-affirming hysterectomy and oophorectomy, there are currently no evidence-based guidelines to define optimal care surrounding many aspects of these surgeries. This commentary reviews the evidence supporting the safety, feasibility, and route of hysterectomy and oophorectomy for transgender men, the benefits and risks of oophorectomy in cisgender women and their extrapolation to transgender men, and the effects of testosterone supplementation in transgender men with and without ovaries. In addition, this article highlights the data gaps surrounding whether oophorectomy should be performed at the time of hysterectomy. Oophorectomy in cisgender women is associated with negative outcomes such as an increase in cardiovascular events and all-cause mortality, most likely attributable to attenuated estrogen levels. There are insufficient outcomes data regarding oophorectomy in transgender men to make the same inference about potential morbidity and mortality. Areas for future research to elucidate best practices are identified in the context of the increasing number of gender-affirming surgeries. As physicians, it is our duty to provide transgender patients with evidence-based recommendations on gynecologic gender-affirming care and to avoid any potential harm.
引用
- Reilly ZP, Fruhauf TF, Martin SJ, et al. Barriers to Evidence-Based Transgender Care: Knowledge Gaps in Gender-Affirming Hysterectomy and Oophorectomy. Obstet Gynecol. 2019. PMID: 31503150. doi:10.1097/AOG.0000000000003472
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。